Peripheral levels of monocytic myeloid-derived suppressive cells before and after first induction predict relapse and survivals in AML patients.

Peterlin, Pierre; Debord, Camille; Eveillard, Marion; Garnier, Alice; Le Bourgeois, Amandine; Guillaume, Thierry; Jullien, Maxime; Béné, Marie C; Chevallier, Patrice

Peterlin, Pierre; Debord, Camille; Eveillard, Marion; Garnier, Alice; Le Bourgeois, Amandine; Guillaume, Thierry; Jullien, Maxime; Béné, Marie C; Chevallier, Patrice.

Afiliação

Peterlin P; Hematology Department, Nantes University Hospital, Nantes, France.
Debord C; Hematology Biology, Nantes University Hospital, Nantes, France.
Eveillard M; Hematology Biology, Nantes University Hospital, Nantes, France.
Garnier A; Hematology Department, Nantes University Hospital, Nantes, France.
Le Bourgeois A; Hematology Department, Nantes University Hospital, Nantes, France.
Guillaume T; Hematology Department, Nantes University Hospital, Nantes, France.
Jullien M; INSERM UMR1232, CRCINA IRS-UN, University of Nantes, Nantes, France.
Béné MC; Hematology Department, Nantes University Hospital, Nantes, France.
Chevallier P; Hematology Biology, Nantes University Hospital, Nantes, France.

J Cell Mol Med ; 26(21): 5486-5492, 2022 11.

Article em En | MEDLINE | ID: mdl-36226545

Assuntos

Leucemia Mieloide Aguda; Recidiva Local de Neoplasia; Adulto; Humanos; Estudos Prospectivos; Monócitos; Células Mieloides

Palavras-chave

ALL; AML; MDSC; diagnosis; monocytes; survivals

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: J Cell Mol Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google